Pharma channel feed

Pfiz­er’s make-or-break quar­ter

7 months ago
Editor's note

Bi­par­ti­san let­ter ques­tions FDA's 'nar­row' in­ter­pre­ta­tion for pri­or­i­ty re­view vouch­ers

7 months ago
FDA+

Await­ing ex­pand­ed ap­provals, Lil­ly and J&J re­lease late-stage da­ta for Crohn's treat­ments

7 months ago
R&D

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

7 months ago
China

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

7 months ago
Startups
Deals

Hun­gary's Olivér Várhe­lyi read­ies to be EU health com­mis­sion­er, pledg­ing ma­jor phar­ma sup­port

7 months ago
Law

House Re­pub­li­cans push for more trans­paren­cy on gov­ern­ment-fund­ed tri­al da­ta

7 months ago
FDA+

Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

7 months ago
FDA+

Post-Hoc: No­vo’s obe­si­ty en­e­mies

7 months ago
Editor's note
Manufacturing

Sanofi re­ports sales jump for Bey­for­tus as RSV an­ti­body chal­lenger from Mer­ck nears

7 months ago

Sanofi backs fi­bro­sis biotech Agomab as it rais­es $89M Se­ries D

7 months ago
Financing
Startups

CDC ad­vi­sors de­cline to rec­om­mend RSV shots to younger at-risk adults, af­firm­ing pri­or guid­ance

7 months ago
FDA+

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

7 months ago
R&D
Outsourcing

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

7 months ago
Health Tech

No­vo Nordisk pe­ti­tions FDA to stop semaglu­tide com­pound­ing over safe­ty risks

7 months ago
FDA+

Adults 50 and up should get pneu­mo­coc­cal vac­cine, CDC ad­vi­sors say, in boost to Pfiz­er and Mer­ck

7 months ago
FDA+

Pfiz­er wins ap­proval to ex­pand RSV vac­cine to adults at high­er in­fec­tion risk

7 months ago
FDA+

No­vo Nordisk asks FDA to pro­hib­it semaglu­tide com­pound­ing, fol­low­ing Eli Lil­ly

7 months ago
FDA+

Al­low­ing No­vo-Catal­ent deal to close would be ‘wrong de­ci­sion’ by an­titrust au­thor­i­ties, Roche CEO says

7 months ago
Manufacturing

Ther­mo Fish­er pre­dicts rev­enue uptick in 2025 as it ex­pects head­winds to ease 

7 months ago
Manufacturing

UK’s price watch­dog says Lil­ly’s Alzheimer’s drug is too cost­ly for broad up­take

7 months ago

Roche says it is un­de­terred by up­com­ing biosim­i­lar threat to Vabysmo

7 months ago
R&D

Sen­a­tors ques­tion whether Pfiz­er, Eli Lil­ly tele­health plat­forms vi­o­late law

7 months ago
Law

Am­gen preps to launch Eylea biosim­i­lar years ear­ly af­ter Re­gen­eron los­es ap­peal

7 months ago
Law
First page Previous page 29303132333435 Next page Last page
A service from the Financial Times